Ligand · JTO
JTO · [2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]phenoxy]methylphosphonic acid
JTO, [2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]phenoxy]methylphosphonic acid (C13 H12 N3 O5 P S, 353.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (2 PDB entries). Every binding site with…
- Component
- JTO
- Formula
- C13 H12 N3 O5 P S
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
JTO in 2 structures; the first of them:
- 7ZSL · human purine nucleoside phosphorylase in complex with JS-196 · JTO A301 · binds GLY32, SER33, ARG84, HIS86, TYR88, ASN115, ALA116, ALA117 and 13 more
- 7ZSQ · human purine nucleoside phosphorylase in complex with JS-555 · JTO A301 · binds GLY35, SER36, ARG88, HIS90, TYR92, ASN119, ALA120, ALA121 and 14 more
Residues it binds most
GLY 9, VAL 9, ALA 9, ASN 9, HIS 9, SER 9, TYR 9, PHE 9, ARG 9, GLU 9 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.